| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.43 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.36 | 4e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.31 | 7e-08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.28 | 3e-08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.06 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.27 | 6e-08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.25 | 3e-06 |